Plexxikon, Inc.

Citeline was delighted to be able to recognize and celebrate excellence across the Japanese pharma, biotech and clinical research industries at the 2nd Citeline Pharma Intelligence Awards Japan, held

Citeline was delighted to be able to recognize and celebrate excellence across the Japanese pharma, biotech and clinical research industries at the 2nd Citeline Pharma Intelligence Awards Japan, held

The end of each year brings a surge in venture capital funding announcements as biopharmaceutical companies and investors seek to close as many deals as possible before everyone takes off for the Dece

Plexxikon, Inc. won a patent infringement lawsuit against Novartis AG on 22 July, in a dispute over intellectual property rights for cancer drug Tafinlar (dabrafenib) and the BRAF inhibitor class,